Technology | November 20, 2009

New Balloon Catheter Aids Endoprosthesis for Aortic Repair

November 18, 2009 – As part of a new partnership deal with QXMédical LLC, W. L. Gore & Associates will distribute the Q50 Stent Graft Balloon Catheter, which is designed for use with aortic stent grafts that treat abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA).

The U.S. Food and Drug Administration (FDA) cleared the catheter in October 2009. This partnership allows Gore to provide customers with a balloon catheter for modeling and occlusion use with the GORE EXCLUDER AAA Endoprosthesis and all other aortic stent grafts.

Gore said the Q50 Stent Graft Balloon Catheter complements the GORE EXCLUDER AAA Endoprosthesis for facilitating endovascular aneurysm repair.

The QXMédical device is a full occlusion balloon catheter that helps aortic stent grafts to fully expand and seal in vessel diameters ranging from 10–50 mm. It offers a short, flexible tip that increases trackability through challenging anatomy, and a compliant polyurethane balloon that inflates and deflates rapidly to give physicians more control. The maker said the Q50 Stent Graft Balloon Catheter offers the broadest inflation diameter range available on the market and is compatible with standard 0.035-inch guide wires and low-profile 12 Fr. introducer sheaths. With 65 and 100 cm length pushable catheter shafts in an 8 Fr. diameter, the device accommodates both abdominal and thoracic applications.

For more information: www.qxmedical.com, www.goremedical.com


Related Content

News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
News | Balloon Catheter

July 15, 2019 — Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon ...

Home July 15, 2019
Home
Subscribe Now